Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of RMB 9.67 [5][4]. Core Views - The company reported a revenue of RMB 2.769 billion for Q1-Q3 2025, a year-over-year decrease of 5.00%, and a net profit attributable to shareholders of RMB 79.04 million, down 48.39% year-over-year [1]. - The company is transitioning from a traditional design firm to a "think tank technology enterprise," focusing on digitalization and emerging growth areas [1]. - The report highlights a significant decline in gross margin due to intensified industry competition, while operational cash flow has shown improvement [3][2]. Financial Performance Summary - For Q3 2025, the company achieved a revenue of RMB 993 million, representing a year-over-year increase of 16.06% and a quarter-over-quarter increase of 2.73%. However, it reported a net loss of RMB 16.36 million, a decline of 252.82% year-over-year [1][2]. - The gross margin for the first nine months of 2025 was 30.58%, down 1.06 percentage points year-over-year, with Q3 gross margin at 28.28%, down 7.47 percentage points year-over-year [2]. - The operating cash flow for the first nine months of 2025 improved, with a net cash inflow of RMB 197 million in Q3, an increase of RMB 221 million year-over-year [3]. Profit Forecast and Valuation - The report has revised down the net profit forecasts for 2025-2027 by 16.03%, 15.66%, and 11.54%, respectively, to RMB 177 million, RMB 191 million, and RMB 212 million [4]. - The company is assigned a PE ratio of 69x for 2025, leading to a target price adjustment to RMB 9.67 from RMB 10.51 [4].
苏交科(300284):Q3盈利承压,现金流改善